ASX:ACL (Australia)  
Australian Clinical Labs Ltd logo

Australian Clinical Labs Ltd

A$ 4.62 (-3.55%) Aug 17
P/E:
5.42
P/B:
4.16
Market Cap:
A$ 966.78M ($ 670.67M)
Enterprise V:
A$ 1.20B ($ 834.39M)
Volume:
1.85M
Avg Vol (2M):
1.11M
Volume:
1.85M
Market Cap A$:
966.78M
Market Cap $:
670.67M
PE Ratio:
5.42
Avg Vol (2-Month):
1.11M
Enterprise Value A$:
1.20B
Enterprise Value $:
834.39M
PB Ratio:
4.16
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download Tutorials

Business Description

Australian Clinical Labs Ltd
1868-1892 Dandenong Road, Clayton, VIC, AUS, 3168
Description
Australian Clinical Labs Ltd is engaged in the provision of pathology services. Its services include all routine pathology tests, advanced pathology, First-trimester screening, and Non-Invasive prenatal testing, Chemical pathology, Haematology, Histopathology, Immunology, Serology and microbiology, Functional pathology, Commercial drug, and alcohol testing. The company has its operations in Victoria, New South Wales, Western Australia, South Australia, Queensland, and the Northern Territory.
Name Current Vs Industry Vs History
Cash-To-Debt 0.1
Equity-to-Asset 0.37
Debt-to-Equity 1.13
Debt-to-EBITDA 0.72
Interest Coverage 199.91
Piotroski F-Score 6/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 4.74
Distress
Grey
Safe
Beneish M-Score -2.69
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
Future 3-5Y Total Revenue Growth Rate Industry Rank -8.97

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 13.75
9-Day RSI 26.53
14-Day RSI 35.17
6-1 Month Momentum % -0.63
12-1 Month Momentum % 13.03

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.63
Quick Ratio 0.55
Cash Ratio 0.12
Days Inventory 29.4
Days Sales Outstanding 29.86
Days Payable 38.24

Dividend & Buy Back

Name Current Vs Industry Vs History
Dividend Yield % 2.51
Dividend Payout Ratio 0.14
Forward Dividend Yield % 17.12
5-Year Yield-on-Cost % 2.51

Financials

ASX:ACL's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil A$) 989.298
EPS (TTM) (A$) 0.884
Beta 0
Volatility % 58.03
14-Day RSI 35.17
14-Day ATR (A$) 0.221921
20-Day SMA (A$) 5.13
12-1 Month Momentum % 13.03
52-Week Range (A$) 4.07 - 6.39
Shares Outstanding (Mil) 201.83

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 6
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Australian Clinical Labs Ltd Filings

Document Form Filing Date
No Filing Data